Revenue segments as reported by the company.

Smokeable Products

Oral Tobacco Products

Wine

All Other

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Marketing, administration and research costs

Asset impairment and exit costs

Amortization of intangibles

General corporate expenses

Corporate asset impairment and exit costs

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Altria

Altria Group, Inc. operates as a holding company, which engages in the manufacture and sale of cigarettes in the United States. It operates through the following segments: Smokeable Products, Oral tobacco products, and Wine. The Smokeable Products segment consists of cigarettes manufactured and sold by PM USA and machine-made large cigars and pipe tobacco manufactured and sold by Middleton. The Oral tobacco products segment is primarily moist smokeless tobacco products (MSTs) through brands like Copenhagen and Skoal as well as on! oral nicotine pouches sold by Helix. The Wine segment, through subsidiary Ste. Michelle Wine Estates Ltd, produces Washington State wines, primarily Chateau Ste. Michelle and 14 Hands, and owns wineries in or distributes wines from several other wine regions. The company was founded in 1919 and is headquartered in Richmond, VA.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Altria reports robust Q4 earnings, focuses on innovation and growth

Altria's Q4 2022 performance reflects resilience amidst industry challenges, with a focus on innovation and shareholder returns. The company's strategic initiatives in smoke-free products and digital engagement underscore its commitment to long-term growth and harm reduction.

Altria reports resilient Q1 performance amid industry challenges and opportunities

Altria's Q1 2023 earnings call highlighted strong performance amidst industry challenges, emphasizing harm reduction and regulatory compliance. The company faces hurdles from inflation, regulatory changes, and evolving consumer behaviors, while focusing on growth opportunities in smoke-free products and strategic investments.

Altria reports solid Q2 earnings, eyes e-vapor growth opportunities

Altria's focus on smoke-free products and NJOY acquisition driving growth.
Challenges in the cigarette industry due to economic pressures and flavor bans.
Opportunities in the e-vapor category and expansion plans in the U.S.
Strong balance sheet and significant capital returns to shareholders.

Altria reports growth in earnings, navigates regulatory challenges in e-vapor

Altria's Q3 2023 earnings call highlighted solid financial performance, strategic focus on e-vapor products, and efforts to combat illegal vape products. The company faces challenges from regulatory uncertainties and illicit products but sees opportunities in expanding NJOY's reach and addressing market gaps.

Altria reports growth in smoke-free products amidst regulatory challenges

Altria's Q4 2023 earnings call highlighted growth in adjusted EPS, strategic focus on smoke-free products, and efforts to combat illicit e-vapor products. The company faces challenges in competitive segments and economic pressures but sees opportunities in new product introductions and regulatory collaborations.

Altria reports mixed Q1 performance, focuses on growth strategies

Altria's Q1 performance showed growth in NJOY and oral tobacco segments, with challenges in EPS decline and economic pressures on consumers.
Strengths include reaffirmed EPS guidance, strategic investments, and focus on combating illicit e-vapor products.
Opportunities lie in maximizing profitability in oral tobacco, product positioning, and capturing transitioning consumers.
Overall, Altria's performance reflects a mix of growth, challenges, and strategic opportunities in navigating market dynamics.

Altria's NJOY drives growth as company navigates e-vapor challenges

Altria's Q2 2024 earnings call showcased strong performance in smoke-free products, highlighting growth in retail share and volume momentum. Despite challenges in the e-vapor category, the company remains focused on responsible regulation and enforcement. With a commitment to shareholder value and long-term growth strategies, Altria is poised for continued success.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Altria Group, Inc. is a holding company, which engages in the manufacture and sale of cigarettes in the United States. It operates through the following segments: Smokeable Products, Oral Tobacco Products, and All Other. The Smokeable Products segment consists of cigarettes manufactured and sold by PM USA, and machine-made large cigars and pipe tobacco manufactured and sold by Middleton. The Oral Tobacco Products segment includes MST and snus products manufactured and sold by USSTC, and oral nicotine pouches manufactured and sold by Helix. The All Other segment refers to the financial results of NJOY, Helix ROW, and the IQOS System heated tobacco business. The company was founded in 1919 and is headquartered in Richmond, VA.

Altria: Ignore The JUUL Drama, The Political Markets Are Improving

BTI vs. MO: Which Stock Is the Better Value Option?

BTI vs. MO: Which Stock Should Value Investors Buy Now?

Since the beginning of the year, tobacco giant Altria Group Inc. (NYSE: MO) saw its stock price dive from just over $50 a share to near $30.

Altria Stock Has Bigger Problems Than COVID-19

British American Tobacco

Nielsen Hlds

Philip Morris

There are several good reasons consumers would be motivated to change their habits.

Will the Pandemic Cause Smokers to Switch to Snus or Nicotine Pouches?

An FTC lawsuit pushed shares of the Marlboro parent lower.

Why Altria Stock Was Sliding Today

Altria Group (NYSE: MO) shares are trading lower on Thursday. The company announced the U.S.

Why Altria's Stock Is Trading Lower Today

The U.S. Federal Trade Commission (FTC) on Wednesday filed an administrative complaint alleging that Altria Group Inc.

Federal Trade Commission Upends Altria’s $12.8 Billion Juul Investment

The regulatory agency says the deal violated antitrust laws.

FTC Sues Altria to Force Unwinding of Its $12.8 Billion Juul Investment

Federal officials have sued to undo tobacco giant Altria's $12.8 billion investment in Juul over concerns that the two companies illegally quashed competition in the e-cigarette industry.

FTC sues to undo Altria’s $12.8 billion deal with Juul

The United States Federal Trade Commission on Wednesday said that it had filed an administrative complaint against the $12.8 billion investment of Altria Group Inc.

FTC Seeks To Undo Altria's $12.8B Juul Investment, Says It Violated Antitrust Laws

The tobacco maker already faced challenges before the coronavirus outbreak. Should investors sound the alarm?

How Safe is Altria and Its Dividend?

The Federal Trade Commission on Wednesday sued to unwind Altria Group Inc.'s MO, -2.74% $12.8 billion investment in Juul Labs Inc.

FTC sues to unwind Altria's $12.8 billion stake in Juul

The U.S. Federal Trade Commission said on Wednesday that it had filed a complaint aimed at forcing Altria Group  to sell its $12.8 billion investment in e-cigarette maker JUUL.

U.S. sues to force Altria to unwind investment in JUUL

Carnival

Tesla

Wednesday's three big stocks are "mavericks" that go their own way - and that just might be a good thing.
The post 3 Big Stock Charts for Wednesday: Altria Group, Tesla, and Carnival Corporation appeared first on InvestorPlace.

3 Big Stock Charts for Wednesday: Altria Group, Tesla, and Carnival Corporation

The stock market has been crushed since late February and the bond market along with it.

How Will Altria Stock Stand Up to COVID-19?

AbbVie

H&R Block

AT&T

Molson Coors Brewing

Dividends are periodic payments a company makes to shareholders out of the profits it generates, provided it has a dividend policy.

7 Safe Dividend Plays For 2020

CenturyLink

Hasbro

These three high-yielding stocks could provide big income and even bigger capital appreciation.

3 Stocks Cracking the 4% Yield Ceiling

Mobile TeleSystems

Valero Energy

If you want a relatively safe 8% (or higher) yield, then these are the income stocks you should be buying.

3 Ultra-High-Yield Dividend Stocks That Can Make You Rich

PepsiCo

The soft drink and tobacco giants are putting out a lot more than their flagship products these days.

Better Buy: PepsiCo vs. Altria

Comparing the trend in Altria Inc. (NYSE: MO) stock over recent months with its trajectory during and after the Great Recession of 2008, we believe that the stock can potentially gain 40% once fears surrounding the coronavirus outbreak are abated.

40% Upside For Altria’s Stock Possible Post COVID-19 Crisis?

Bristol-Myers

Newmont Mining

Thanks to the coronavirus-fueled market decline, these high-quality stocks are at bargain-bin prices.

News for Altria Stock (MO)